Ascendis Pharma(MX:ASND1N)
MX$4,165.550.00 (0.00%)
MX:ASND1N
Ascendis Pharma earnings date
MX$4,165.55
At close:0.00 (0.00%)
Ascendis Pharma (ASND1N) Q3 2025 Earnings Report
0 Followers
MX:ASND1N Q3 2025 EPS Results
- Actual EPS
- -MXN 20.28
- Consensus EPS
- -MXN 4.95
- Beat/Miss
- Missed by -MXN 15.33
- One Year Ago EPS
- -MXN 34.88
MX:ASND1N Q3 2025 Revenue Results
- Actual Revenue
- MXN 4.61B
- Expected Revenue
- MXN 4.32B
- Beat/Miss
- Beat by +MXN 281.20M
- YoY Revenue Growth
- +292.96%
Earnings Announcement Details
- Quarter
- Q3 2025
- Date
- 11/12/2025
- Time
- After Close
- Conference Call
- Wednesday, November 12, 2025
MX:ASND1N Upcoming Earnings
Ascendis Pharma's next earnings date is estimated for February 17, 2027, based on past reporting schedules.
Q3 2025 Earnings Call Audio
MX:ASND1N Q3 2025 Earnings Call
0:00 / 0:00
Q3 2025 Earnings Slide Deck
No slide deck is available for this earnings event.
Q3 2025 Earnings Call Summary
No earnings call summary is available for this earnings event.
MX:ASND1N Earnings History
| Report Date | Fiscal Quarter | Forecast / EPS | Last Year's EPS | EPS YoY Change | Press Release |
|---|---|---|---|---|---|
| Feb 17, 2027 | 2026 (Q4) | 32.85- | -11.15 | ― | ― |
| Nov 12, 2026 | 2026 (Q3) | 16.1221.90 | -20.28 | 208.00% (+42.18) | |
| Aug 13, 2026 | 2026 (Q2) | 30.3657.39 | -16.63 | 445.12% (+74.02) | |
| May 07, 2026 | 2026 (Q1) | ―197.72 | -32.04 | 717.09% (+229.76) | |
| Feb 11, 2026 | 2025 (Q4) | -1.62-11.15 | -12.98 | 14.06% (+1.83) | |
| Nov 12, 2025 | 2025 (Q3) | -4.95-20.28 | -34.88 | 41.86% (+14.60) | |
| Aug 07, 2025 | 2025 (Q2) | -26.08-16.63 | -38.73 | 57.07% (+22.10) | |
| May 01, 2025 | 2025 (Q1) | -29.75-32.04 | -46.64 | 31.30% (+14.60) | |
| Feb 12, 2025 | 2024 (Q4) | -19.95-12.98 | -31.23 | 58.44% (+18.25) | |
| Nov 14, 2024 | 2024 (Q3) | -31.74-34.88 | -54.55 | 36.06% (+19.67) |
The table shows recent earnings report dates and whether the forecast was beat or missed. See the change in forecast and EPS from the previous year.
Beat Missed

